Chris Whitfield is a Professor and Tier 1 Canada Research Chair at the University of Guelph. He obtained his PhD at Edinburgh and was a postdoctoral fellow at the University of California (Davis) and the University of Calgary, before his faculty appointment at Guelph in 1984. He was the founding chair of the Department of Molecular & Cellular Biology from 2002-13 and was a member of the University’s Board of Governors for a 3-year term ending in 2013. Dr. Whitfield’s research focuses on the assembly of cell-surface glycoconjugates in pathogenic bacteria. His research group has provided broad insight into how these large molecules are synthesized, how they are exported through bacterial cell walls, and their potential as targets for antimicrobial therapy. Dr. Whitfield has held consultancies with biotechnology and pharmaceutical companies in Canada, the US and Europe and is a current member of the Scientific Advisory Board of the Alberta Glycomics Centre. His research contributions have been recognized with awards including the premier award from the Canadian Society of Microbiologists (the CSM/Roche Prize), a CIHR Senior Investigator Award, and Fellowship in the American Academy of Microbiology. Dr. Whitfield was elected to Fellowship in the Royal Society of Canada in 2007.
- NEWS & EVENTS
- CORE SERVICES